LyGenesis
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $8.7M
Investors
- 2
About LyGenesis
Based in the US, LyGenesis, Inc., founded in 2017 in Pittsburgh, US, focuses on developing advanced cell therapies. The company has not undergone any major pivots since its inception. It was co-founded by Michael Hufford and Paulo Fontes.731 mn.LyGenesis specializes in pioneering cell therapies that address significant unmet medical needs, particularly in the areas of Type 1 diabetes and end-stage liver and renal diseases. The company utilizes the patient’s lymph nodes as bioreactors to cultivate functioning ectopic organs, allowing a single donated liver to potentially treat multiple patients suffering from end-stage liver disease. The outpatient procedure to engraft these therapies is performed via endoscopic ultrasound, significantly reducing medical risks and costs compared to traditional organ transplants.LyGenesis generates revenue through its clinical-stage cell therapy products designed for hospitals and specialized medical centers. Their transaction model includes partnerships with healthcare providers who integrate these therapies into treatment protocols for life-threatening conditions.In October 2023, LyGenesis Inc.gov Identifier: NCT04496479) and advance its pipeline of cell therapies. Additionally, there are intentions to expand into new geographic markets in North America and Europe, enhancing accessibility for patients in need of organ replacement therapies.
Who invested in LyGenesis
2 investors across 1 round
See all investors in LyGenesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 5, 2023
Amount
$8.7M
Investors
Questions about LyGenesis
Who invested in LyGenesis?
LyGenesis has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LyGenesis raised?
LyGenesis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LyGenesis last raise money?
LyGenesis's most recent round on record is a Series A, in Oct 2023.
What does LyGenesis do?
Based in the US, LyGenesis, Inc.
Where is LyGenesis headquartered?
LyGenesis is headquartered in Pittsburgh, US.
Which VCs invest in companies like LyGenesis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at LyGenesis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like LyGenesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.